PCPA in the news – Big names meet to talk cancer

pharma in focus 4th May 2023.

Big names are readying to debate “the true value of oncology” at the Private Cancer Physicians of Australia’s (PCPA) 2023 conference over the weekend in Melbourne – just days ahead of the 2023-24 Federal Budget.

The ‘Embracing the Challenge: Advancing Cancer Care’ conference will be held at the InterContinental hotel, The Rialto, and is sponsored by a range of pharma’s including Diamond Sponsor Roche and Gold Sponsors  Gilead, Kite, and Servier.

Click here to read the full article.

CPD 2023 – are you ready?

The Medical Board of Australia’s new CPD rules are here. They are complex and mandatory.

80% of our members say they want help in meeting the additional requirements.

The PCPA is developing a bespoke digital toolkit, CPD4MedProfessional, designed specifically for our members.

We need to know where the knowledge-capacity gaps are, so we can be sure the platform is curated to meet the needs of our Consultants.

Please complete this 3 minute PCPA CPD survey. The toolkit, and survey results, will be revealed at the ASM in Melbourne

PCPA in the news – Private Cancer physicians partner with industry on new patient-focused platform

BioPharmaDispath 27 Feb 2023.

Australia’s peak body of private cancer specialists has partnered with companies to launch a suite of interactive education and engagement platforms with the aim of enhancing the cancer care journey for patients.

The president of the Private Cancer Physicians of Australia (PCPA), Associate Professor Christopher Steer, said prioritising the needs of Australians with cancer, and those who care for them, was the driving force behind the organisation’s inaugural ‘Strategic Alliance Partnership’ program.

Click here to read full article.

PCPA in the news – Company backs cancer podcast

Pharma in Focus 28 Feb 2023.

The Private Cancer Physicians of Australia (PCPA) has kicked off its Strategic Alliance Partnership program with a podcast supported by Servier.

Outgoing CEO of Servier Australia, Brad Lloyd, said the company was proud to be a founding Strategic Partner with the PCPA, which aims to advance the cancer care journey of Australians, particularly through the private system. “We’re committed to improving the lives of all Australian cancer patients today and working together to develop better treatments for tomorrow,” Lloyd said.

Click here to read full article.


Renew your membership now and receive a free gift.*

Current PCPA members are now able to renew your membership for 2022- 2023.

Renewing your membership is easy online by clicking on the below link

Plus for a limited time only, we are giving away one of 12 copies of “The Patient Doctor” by Dr Ben Bravery.* A powerful and inspiring memoir about how one man’s cancer diagnosis led to him becoming a doctor and advocate for change in the healthcare system.

Dr Ben Bravery spoke at the recent PCPA Advanced Trainee Program and his presentation was both inspirational and memorable.

If you require any assistance with your membership renewal, please contact PCPA Secretariat, Jennifer Burgess on j.burgess@amaq.com.au or 07 3872 2234.

*Conditions apply. While stocks last.

The Patient Doctor by Dr Ben Bravery is available to purchase online from
Hachette Australia

Election Manifesto cover

Election Manifesto

Election Manifesto coverDate: 24 March 2022

PCPA’s core mission is the delivery of the best treatment and advocacy for patients with cancer, regardless of where they might live, or what their socioeconomic circumstances. We strive, each day, to rid the scourge of cancer from our patients and provide comfort and support to them and their families.

We are acutely aware, and deeply concerned, at the overwhelming and often, unexpected financial costs that come with the diagnosis of cancer.

As cancer physicians providing high quality, personalised, patient-centred care, we work very hard to control the out-of-pocket expenses that are within our control. As patient advocacy leaders, we see first-hand the often-extreme choices some patients feel they must make. Sell the house or have treatment? Retain childcare services or have treatment? Keep working or take the much-needed time off to recover?

Cancer treatment should never come with a question mark over whether the patient can afford it or not.

The PCPA and the Rare Cancers Australia is advocating the next Australian Government adopts the recommendations we have made in our combined ‘Cancer Care, No Gaps’ election manifesto.

Together we focus on the low cost and high impact measures that, if implemented, can and will have an immediate positive effect in the lives of Australian cancer patients and their families.

Download Election Manifesto here (PDF)

PCPA secures a reversal of MBS Telehealth cuts to phone consults

Date: 16th January 2021

Dear Members,

We are very pleased to inform you that after a very short but intense campaign of media and advocacy over Christmas, the PCPA was able to secure a reversal of the sudden cuts to Telehealth phone consults (item number 91835).

The item will be re-instated on Tuesday January 18 and backdated to January 01, 2022. There was a further addition of MBS rebates for specialist phone consults with in-patients. We will share the full list of MBS changes when it is available.

We will continue to advocate for the re-instatement of the 50% MBS loading for video consultations with regional and rural patients (MBS item 112).

We will prepare a short letter that you should provide to your patients, impacted by this removal, so they too can become active advocates with their own local MP.

Please click here to view media release that went out on the 16th January and the joint release by Ministers Hunt and Gillespie.

View pdf of the full list of MBS items re-instated- as provided to us by Minister Hunt.